Skip to main content
. 2015 Sep 11;3(3):730–750. doi: 10.3390/vaccines3030730

Figure 4.

Figure 4

Particle size distribution (Size) and polydispersity index (PdI) after one year storage at 4 °C in suspension; NP B: Chitosan/TPP/Poly (I:C) nanoparticles without peptides; NP A1: Chitosan/TPP/Poly (I:C) nanoparticles with 1338a adsorbed at surface; NP A2: Chitosan/TPP/Poly (I:C) nanoparticles with 1338aa and PADRE adsorbed at surface; NP E: Chitosan/TPP/Poly (I:C) nanoparticles with 1338aa and PADRE encapsulated. Results are presented as mean ± standard deviation (n = 3).